SCHEMBL21628586

SCHEMBL21628586

CCCc1ccc(Oc2ncc(C(=O)N(C)C)cc2F)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
HPGD P15428 1/20 0.41
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
RAB9A P51151 2/20 0.38
NPC1 O15118 1/20 0.38
MAPT P10636 1/20 0.38
KMT2A Q03164 1/20 0.38
PTGER4 P35408 2/20 0.37
PLA2G4A P47712 1/20 0.37
THRB P10828 1/20 0.36
VNN1 O95497 1/20 0.36
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36
LMNA P02545 1/20 0.36
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
F2 P00734 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21628763 0.93 PLA2G4A (0.41) ALDH1A1SMN1; SMN2HPGDMAPTKMT2A
SCHEMBL21628577 0.92 PLA2G4A (0.45) ALDH1A1SMN1; SMN2HPGDPLA2G4ATHRB
SCHEMBL21628638 0.91 PLA2G4A (0.46) PLA2G4ATHRB
SCHEMBL21628376 0.91 SMN1; SMN2 (0.43) ALDH1A1SMN1; SMN2HPGDMAPTPTGER4
SCHEMBL21628805 0.87 PTGER4 (0.46) ALDH1A1SMN1; SMN2SENP8SENP7SENP6
SCHEMBL21628512 0.86 OPRM1 (0.43) ALDH1A1SENP8SENP7SENP6RAB9A
SCHEMBL21628424 0.85 VNN1 (0.42) ALDH1A1SMN1; SMN2SENP8SENP7SENP6
SCHEMBL21628703 0.84 SMN1; SMN2 (0.46) ALDH1A1SMN1; SMN2HPGDRAB9ANPC1
SCHEMBL21628761 0.84 MAOB (0.46) ALDH1A1SENP8SENP7SENP6MAPT
SCHEMBL21628686 0.84 PLK1 (0.51) ALDH1A1SMN1; SMN2HPGDSENP8SENP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12600696-B2 Aromatic compounds Xeniopro GmbH (DE) 2026-04-14 US disclosed
US-20230406814-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2023-12-21 US disclosed
US-20230150923-A1 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2023-05-18 US disclosed
US-11591289-B2 Aromatic compounds Xeniopro GmbH (DE) 2023-02-28 US disclosed
US-11591289-B2 Aromatic compounds Xeniopro GmbH (DE) 2023-02-28 US disclosed
US-20220348535-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2022-11-03 US disclosed
US-20210107863-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2021-04-15 US disclosed
US-20200031763-A1 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2020-01-30 US disclosed
US-20200031763-A1 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2020-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150923-A1 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK ALDH1A1 717/4885SMN1; SMN2 796/4885HPGD 2579/4885
US-20220348535-A2 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK ALDH1A1 717/4885SMN1; SMN2 796/4885HPGD 2579/4885
US-11591289-B2 Aromatic compounds AHR, TYR, MUSK ALDH1A1 900/4885SMN1; SMN2 1107/4885HPGD 2313/4885
US-20210107863-A2 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK ALDH1A1 717/4885SMN1; SMN2 796/4885HPGD 2579/4885
US-12600696-B2 Aromatic compounds CCR1, CCRL2, AHR ALDH1A1 929/4885SMN1; SMN2 919/4885HPGD 3694/4885
US-20230406814-A2 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK ALDH1A1 717/4885SMN1; SMN2 796/4885HPGD 2579/4885
US-20200031763-A1 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK ALDH1A1 717/4885SMN1; SMN2 796/4885HPGD 2579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.